🇺🇸 FDA

Company profile · Sponsor

Turn

Turn Therapeutics

TTRX · NYSE pharma WESTLAKE VILLAGE, CA, USA
Pipeline
6
Drugs
0
Patents
8

Quick answer

Turn (TTRX) is a pharma company. headquartered in WESTLAKE VILLAGE, CA, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker TTRX
Exchange NYSE
Company type pharma
Headquarters WESTLAKE VILLAGE, CA, USA
SEC CIK 0002023016

Pipeline (6)

Search pipeline →

  1. MiLES

    Turn

    Cancer

    phase 3 other active

    1 trial

  2. GX-03

    Turn

    Covid19

    phase 2 small molecule completed

    1 trial

  3. GX-03

    Turn

    Eczema Atopic Dermatitis

    phase 2 other active

    1 trial

  4. Repotrectinib (TPX-0005)

    Turn

    Advanced Solid Tumors

    phase 2 small molecule active

    1 trial

  5. Repotrectinib (TPX-0005), Repotrectinib (TPX-0005), Repotrectinib (TPX-0005)

    Turn

    Advanced solid tumors

    phase 2 small molecule active

    1 trial

  6. First-in-human Study to Test Safety and Anti-tumor Activity of a Novel Drug for Patients with Advanced Solid Tumor Harboring Genetic Alterations in MET

    Turn

    Phase 1: Advanced solid tumors harboring genetic alterations in MET

    phase 1 other active

    1 trial

Patents (8)

Search patents →

  1. US 12310968

    Chiral diaryl macrocycles and uses thereof

    Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12252488

    HPK1 antagonists and uses thereof

    Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12215105

    HPK1 antagonists and uses thereof

    Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12187739

    Diaryl macrocycle polymorph

    Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12071442

    Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonists

    Expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11981684

    Macrocyclic compounds and uses thereof

    Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11926625

    HPK1 antagonists and uses thereof

    Expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11802292

    Modified orthopoxvirus vectors

    Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Turn?

Turn (TTRX) is a pharma company. headquartered in WESTLAKE VILLAGE, CA, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does Turn sponsor?

We track 6 ClinicalTrials.gov-linked programs for Turn, including MiLES and 5 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Turn company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.